MOLECULAR PARTNERS AG Annual Research And Development Expense in CHF from 2019 to 2024

Taxonomy & unit: ifrs-full: CHF
Summary: Molecular Partners Ag annual/quarterly Research And Development Expense history and growth rate from 2019 to 2024.
Molecular Partners Ag Research And Development Expense for the quarter ending June 30, 2023 was ₣11.6M, a 7.47% decline year-over-year.
Molecular Partners Ag annual Research And Development Expense for 2024 was ₣48.6M, a 0.37% decline from 2023.
Molecular Partners Ag annual Research And Development Expense for 2023 was ₣48.8M, a 3.87% decline from 2022.
Molecular Partners Ag annual Research And Development Expense for 2022 was ₣50.7M, a 8.92% decline from 2021.

Research And Development Expense, Annual (CHF)

Research And Development Expense, YoY Annual Growth (%)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
2024	48.6M	-180K	-0.37%	Jan 1, 2024	Dec 31, 2024	20-F	2025-03-06
2023	48.8M	-1.97M	-3.87%	Jan 1, 2023	Dec 31, 2023	20-F	2025-03-06
2022	50.7M	-4.97M	-8.92%	Jan 1, 2022	Dec 31, 2022	20-F	2025-03-06
2021	55.7M	-357K	-0.64%	Jan 1, 2021	Dec 31, 2021	20-F	2024-03-14
2020	56.1M	+12.6M	+28.9%	Jan 1, 2020	Dec 31, 2020	20-F	2023-03-09
2019	43.5M			Jan 1, 2019	Dec 31, 2019	20-F	2022-03-15

Showing 1 to 6 of 6 entries

* An asterisk sign (*) next to the value indicates that the value is likely invalid.